Entity

Eli Lilly

American pharmacist, Union Army officer, businessman, philanthropist

Express your sentiment! Sign in!
Entity sentiment
1
Eli Lilly receives FDA approval for eczema treatment Ebglyss
Eli Lilly
Efsitora alfa shows A1C reduction in type 2 diabetes patients
Eli Lilly
Eli Lilly launches affordable Zepbound weight loss drug options
Eli Lilly
Bipartisan Lawmakers Demand FDA Inquiry into Clinical Trials in China
Pfizer People's Republic of China Eli Lilly
Business
Analyst Calls for Top Stocks
ExxonMobil Nvidia Amazon AMD Eli Lilly
Business
Analysts See Growth Potential for Eli Lilly, Vista Energy, and AMD
Vista Energy Storage System AMD Eli Lilly
Business
Big Stock Moves: Eli Lilly, Paramount Global, and Palo Alto Networks
Paramount Global Palo Alto Networks Eli Lilly
Business
Stock Market Update: Eli Lilly Shows Positive Signs
Eli Lilly
Business
Eli Lilly Growing against Novo Nordisk
Novo Nordisk Eli Lilly
Business
Top Analyst Calls for Various Companies
Nvidia Tesla, Inc. Starbucks Eli Lilly Coinbase TJX Companies
Business
Eli Lilly's Strong Earnings Boosts Stock
Eli Lilly
Business
Cramer Urges Investors to Focus on Individual Stocks Over Macroeconomic Trends
Jim Cramer Eli Lilly
Eli Lilly Shows Progress in Weight Loss Drug Zepbound
Mohit Bansal Wells Fargo Eli Lilly
Business
Eli Lilly Sees Big Sales from Mounjaro and Zepbound
Eli Lilly
Business
Eli Lilly's Earnings Continue to Rise; TJX Remains Strong
TJX Companies Eli Lilly
Business
Top Wall Street Picks: Nvidia, Amazon, and More
Nvidia Amazon Synchrony Eli Lilly Sweetgreen Burlington
Business
Stock Moves: McKesson and Monster Down, Eli Lilly and Zillow Up
McKesson Corporation Monster Beverage Eli Lilly Zillow
Business
Premarket Stock Moves: Eli Lilly, Under Armour, Warner Bros
Eli Lilly Under Armour Warner Bros. Discovery
Business
Market Reactions to Earnings Reports: Eli Lilly and Under Armour Shine, Dutch Bros Struggles
Eli Lilly Under Armour Warner Bros. Discovery
Business
Eli Lilly's Earnings Outlook
Eli Lilly
Business
Eli Lilly Earnings Report: Wall Street Focuses on Zepbound Performance
Novo Nordisk Ozempic Eli Lilly
Business
Market Updates: Analyst Upgrades and Downgrades
Nvidia Apple Amazon Coinbase Tesla, Inc. Live Nation Eli Lilly
Market Rally and FDA Approval Boosts Eli Lilly's Prospects
Food and Drug Administration Eli Lilly
Business
Wall Street Faces Potential Pullback After Strong First Half of 2024
Microsoft Eli Lilly
Business
Eli Lilly's GLP-1 Revenue Surges and Raises Future Guidance
Eli Lilly
Business
Stock market update: eli lilly and 3m see gains, while microstrategy and chegg experience losses midday
Eli Lilly MicroStrategy Chegg
Business
Eli lilly sees profit boost with new drugs despite supply issues
Eli Lilly
Health
Eli Lilly climbed on win for rival weight-loss drug, and we still feel good about Abbott Labs
Eli Lilly
You've reached the end